A History of Outperforming Analyst Forecasts and Beating the Odds: Alignment Healthcare Inc (ALHC)

With 4.27 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.81 million shares. The 52-week range on ALHC shows that it touched its highest point at $15.85 and its lowest point at $4.46 during that stretch. It currently has a 1-year price target of $16.38. Beta for the stock currently stands at 1.50.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ALHC was up-trending over the past week, with a rise of 13.87%, but this was up by 2.11% over a month. Three-month performance surged to 26.49% while six-month performance rose 75.57%. The stock gained 174.20% in the past year, while it has gained 37.96% so far this year. A look at the trailing 12-month EPS for ALHC yields -0.67 with Next year EPS estimates of -0.25. For the next quarter, that number is -0.14. This implies an EPS growth rate of 35.69% for this year and 41.25% for next year. EPS is expected to grow by 44.95% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -22.95%.

Float and Shares Shorts:

At present, 191.78 million ALHC shares are outstanding with a float of 109.86 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ALHC since 10 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.64264 being high and -$0.72298 being low. For ALHC, this leads to a yearly average estimate of -$0.68281. Based on analyst estimates, the high estimate for the next quarter is $0.03 and the low estimate is $0.0. The average estimate for the next quarter is thus $0.01.

Summary of Insider Activity:

Insiders traded ALHC stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.